NCT02967614 - KJ-TFC-004 Drug-drug Interaction Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

April 1, 2018

Conditions

GlaucomaEye DiseasesOcular Hypertension

Interventions

DRUG

[A]

One eye drop(about 40ul) / Day1 \~ Day8 / BID

DRUG

[B]

One eye drop(about 40ul) / Day1 \~ Day92 / BID

DRUG

[A]+[B](1)

One eye drop(about 40ul) / Day9 \~ Day100 / BID

DRUG

[A]+[B](2)

One eye drop(about 40ul) / Day93 \~ Day100 / BID

Trial Locations (1)

Clinical Trial Center, Seoul National University Hospital, Seoul